|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$521,138
|
N/A
|
(NCI)
|
|
Defining mechanisms and targets in Wnt addicted human malignancies (PQ22)
|
1R01CA170702-01
|
$351,713
|
$351,713
|
AARONSON, STUART
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
Molecular interactions and restoration strategies of PTEN and p53 in gliomas
|
5R01CA134843-03
|
$309,964
|
$309,964
|
ABOUNADER, ROGER
|
UNIVERSITY OF VIRGINIA
|
|
Sphingolipid Signaling in Mammals
|
ZIABC011187
|
$494,758
|
$247,379
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-10S3
|
$176,626
|
$14,130
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Children's Oncology Group Chair's Grant
|
7U10CA098543-10
|
$26,733,729
|
$2,138,698
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas
|
1K99CA160775-01A1
|
$104,638
|
$104,638
|
Ahmed, Atique
|
UNIVERSITY OF CHICAGO
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$35,307
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$4,315
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$118,614
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Protein Kinase C and GSTP1 interactions in glioma drug resistance
|
5R01CA127872-05
|
$313,989
|
$313,989
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
P53-dependent GSTP1 Gene Regulation and Glioma Drug Resistance
|
5R01CA153050-03
|
$316,002
|
$316,002
|
Ali-Osman, Francis
|
DUKE UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,264,778
|
$12,648
|
Alter, Blanche
|
DCEG (NCI)
|
|
Therapeutic approaches that target cancer cell metabolism
|
5K23CA120862-05
|
$137,295
|
$41,189
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$80,656
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-03
|
$321,854
|
$64,371
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
Children's Oncology Group Statistics and Data Center Grant
|
7U10CA098413-10
|
$5,792,621
|
$463,410
|
ANDERSON, JAMES
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Understanding Mechanisms of Resistance to Anti-angiogenic Treatments
|
1R01CA160216-01A1
|
$325,626
|
$325,626
|
ARBAB, ALI
|
HENRY FORD HEALTH SYSTEM
|
|
In vivo detection of involvement of endogenous BM progenitor cells in glioma
|
1R01CA172048-01
|
$303,988
|
$303,988
|
ARBAB, ALI
|
HENRY FORD HEALTH SYSTEM
|
|
Mixed-Ligand Targeting of a Nano-Pharmaceutical Against GBM Stem Cells
|
3U43CA156841-01A1S1
|
$43,019
|
$43,019
|
Armentrout, Steven
|
PARABON NANOLABS, INC.
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
|
5R01CA155769-02
|
$348,600
|
$348,600
|
BADIE, BEHNAM
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Protein Folding Mechanism
|
ZIABC010276
|
$258,211
|
$206,569
|
Bai, Yawen
|
CCR (NCI)
|
|
Normal & Neoplastic Growth in the Brain
|
3P01CA096832-09S1
|
$98,000
|
$98,000
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Normal & Neoplastic Growth in the Brain
|
5P01CA096832-09
|
$1,932,367
|
$1,932,367
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Pten and P13K regulation of growth and neoplasia in the brain
|
5R01CA135554-10
|
$389,271
|
$389,271
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB
|
5R01CA075080-14
|
$295,242
|
$147,621
|
BALDWIN, ALBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Clinical and Molecular Studies of Malignant Brain Tumors
|
2K24CA125440-06
|
$185,972
|
$139,479
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-12
|
$764,863
|
$764,863
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIABC010622
|
$226,824
|
$45,365
|
Bates, Susan
|
CCR (NCI)
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$8,210
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA042014-23S1
|
$75,000
|
$2,250
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-23
|
$1,454,512
|
$43,635
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
The Gulf Coast MBCCOP
|
3U10CA128536-05S1
|
$391,891
|
$3,919
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
2U10CA035101-27
|
$669,579
|
$13,392
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Surgical Oncology Research Training
|
5T32CA106493-08
|
$45,805
|
$11,451
|
BEHRNS, KEVIN
|
UNIVERSITY OF FLORIDA
|
|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-03
|
$245,762
|
$245,762
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Targeting the JAK/STAT-3 Pathway Signaling Axis in Glioma
|
1R01CA158534-01A1
|
$303,988
|
$303,988
|
Benveniste, Etty
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$781,521
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$3,960
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$5,250
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$3,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-30S1
|
$50,000
|
$1,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-30S2
|
$75,000
|
$1,500
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-30
|
$2,547,570
|
$50,951
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-19
|
$543,533
|
$10,871
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Systematic Development of Novel, Druggable Cancer Targets
|
1U01CA168397-01
|
$887,144
|
$887,144
|
BERENS, MICHAEL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
|
BRAIN TUMOR SPORE GRANT
|
3P50CA097257-10S1
|
$599,883
|
$599,883
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Mechanism and therapeutic targeting of evasive resistance to antiangiogenic drugs
|
5R01CA099948-10
|
$526,187
|
$263,094
|
BERGERS, GABRIELE
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Pediatric Oncology Research Training Program
|
2T32CA009351-34
|
$235,116
|
$23,512
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Brain for this search: $171,301,440
|